Editas Medicine (EDIT), Celgene Corp. (CELG) Update Collaboration Agreement to Develop/Commercialize Autologous & Allogeneic T Cell Medicines

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. MSFT
10. IBM

Go back to Editas Medicine (EDIT), Celgene Corp. (CELG) Update Collaboration Agreement to Develop/Commercialize Autologous & Allogeneic T Cell Medicines
Celgene Corp. (NASDAQ: CELG) Delayed: 108.24 --0 (-0%)
Previous Close $108.24    52 Week High $127.00 
Open $7.85    52 Week Low $93.05 
Day High $108.24    P/E 32.12 
Day Low $108.24    EPS $3.37 
Volume 0       

(NASDAQ: EDIT) Delayed: 2.80 --0 (-0%)
Previous Close $2.80    52 Week High $43.99 
Open $2.80    52 Week Low $12.43 
Day High $2.80    P/E N/A 
Day Low $2.80    EPS $0.00 
Volume 2,394